We will be hiring 20 ambitious, curious, creative, energetic, fresh bright minds to take part in the research and training activities on Targeted Delivery of Nucleic Acid Therapeutics. These Doctoral Candidates will be trained by an excellent team of academics and INDUSTRY which are World leading experts in this field.

doctoral candidates will take part in creating the first steps of new molecular approaches for futuristic medical treatments.

This 4-year Doctoral Network programme will officially start by 1st of October 2024!

Training

Training programme on Nucleic Acid Therapeutics, which will include seminars on chemistry, physics, biology and business side of molecular machines. 20 Doctoral Candidates will be trained on how to synthesise, characterise and utilise molecular machines in a biological environment.

Learn More on Training

Research

20 collaborative projects have been designed between the academic and industrial scientists of NATPRIME. Each of these projects are aiming to solve a critical problem to advance in the use of nanoparticles for the delivery of nucleic acid therapeutics. We believe these small steps in scientific development will create the next generation of biomedical treatment methods.

Learn more on Research

ALL OUR POSITIONS ARE OPEN FOR APPLICATION UNTIL they are filled. The first application deadline is 1st of novembER 2024. PLEASE COMPLETE THE FORM ON THE APPLICATION PAGE and CHOOSE THE PROJECTS YOU WOULD LIKE TO BE CONsIDERED FOR.

eu_flag.jpg

FUNDED BY EU

NATPRIME is a European project funded by the European Union’s Horizon Europe research and innovation programme under the Marie Skłodowska-Curie grant agreement n° 101168881. It is also co-funded by UK Guarantee Scheme.